Clinical Trial Update: Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel, bevacizumab and pemetrexed in untreated advanced non-small cell lung cancer using web-based data collection and patient sel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-30